|
• Patients on long term dialysis treatment (>12 months) with sHPT
|
• Primary or Tertiary hyperparathyroidism (hyperparathyroidism after kidney transplantation)
|
|
• PTH ≥ tenfold above upper normal value
|
• Familial hyperparathyroidism(MEN I, MEN II, hereditary hyperparathyroidism)
|
|
• Age equal or greater 18 years
|
• History of neck explorations for thyroid/parathyroid disorders
|
|
• Informed consent
|
• Malignant disease of the thyroid glands
|
| |
• Bleeding disorder/coagulopathy
|
| |
• Severe psychiatric or neurologic disease
|
| |
• Drug- and/or alcohol-abuse
|
| |
• Participation in another intervention-trial with interference of intervention and outcome
|
| |
• Inability to follow the instructions given by the investigator (e.g. insufficient command of language)
|
